Adverum Biotechnologies Inc’s filing revealed that its 10% Owner Leonard Braden Michael acquired Company’s shares for reported $0.9 million on Apr 22 ’25. In the deal valued at $3.00 per share,300,000 shares were bought. As a result of this transaction, Leonard Braden Michael now holds 3,057,526 shares worth roughly $8.9 million.
Then, Leonard Braden Michael bought 50,000 shares, generating $148,950 in total proceeds. Upon buying the shares at $2.98, the 10% Owner now owns 191,800 shares.
Before that, Leonard Braden Michael bought 19,566 shares. Adverum Biotechnologies Inc shares valued at $85,668 were divested by the 10% Owner at a price of $4.38 per share. As a result of the transaction, Leonard Braden Michael now holds 2,742,317 shares, worth roughly $7.98 million.
Oppenheimer initiated its Adverum Biotechnologies Inc [ADVM] rating to an Outperform in a research note published on June 25, 2024; the price target was $25. A number of analysts have revised their coverage, including H.C. Wainwright’s analysts, who began to cover the stock in late April with a ‘”a Buy”‘ rating. Truist also remained covering ADVM and has increased its forecast on July 07, 2022 with a “Buy” recommendation from previously “Hold” rating. Cantor Fitzgerald revised its rating on July 23, 2021. It rated ADVM as “a Neutral” which previously was an “an Overweight”.
Price Performance Review of ADVM
On Friday, Adverum Biotechnologies Inc [NASDAQ:ADVM] saw its stock fall -2.02% to $2.91. Over the last five days, the stock has lost -0.68%. Adverum Biotechnologies Inc shares have fallen nearly -37.69% since the year began. Nevertheless, the stocks have fallen -73.55% over the past one year. While a 52-week high of $10.98 was reached on 03/21/25, a 52-week low of $2.71 was recorded on 04/21/25. SMA at 50 days reached $4.13, while 200 days put it at $5.92.
Levels Of Support And Resistance For ADVM Stock
The 24-hour chart illustrates a support level at 2.81, which if violated will result in even more drops to 2.71. On the upside, there is a resistance level at 3.01. A further resistance level may holdings at 3.11. The Relative Strength Index (RSI) on the 14-day chart is 35.79, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -0.26, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 83.40%. Stochastics %K at 15.29% indicates the stock is a buying.
How much short interest is there in Adverum Biotechnologies Inc?
A steep rise in short interest was recorded in Adverum Biotechnologies Inc stocks on 2025-04-15, dropping by 56911.0 shares to a total of 1.43 million shares. Yahoo Finance data shows the prior-month short interest on 2025-03-14 was 1.48 million shares. There was a decline of -3.99%, which implies that there is a negative sentiment for the stock.
